Antimicrobial agent | No. (%) | Â | P-value |
---|---|---|---|
CTXNS-En (n = 37) | CTXS-En (n = 74) | ||
Ceftazidime | 5 (14%) | 73 (99%) | <0.01 |
Cefozopran | 12 (32%) | 73 (99%) | <0.01 |
Cefepime | 21 (57%) | 70 (95%) | <0.01 |
Flomoxefa | 22 (59%) | 56 (76%) | 0.12 |
Meropenem | 36 (97%) | 74 (100%) | <0.33 |
Amoxicillin-clavulanate | 13 (35%) | 46 (62%) | <0.01 |
Piperacillin-tazobactam | 25 (68%) | 74 (100%) | <0.01 |
Amikacin | 37 (100%) | 74 (100%) | 1.00 |
Gentamicin | 28 (76%) | 64 (86%) | 0.18 |
Ciprofloxacin | 18 (49%) | 65 (88%) | <0.01 |
Levofloxacin | 19 (51%) | 65 (88%) | <0.01 |
Sulfamethoxazole-trimethoprim | 20 (54%) | 57 (77%) | 0.02 |
Multidrug resistance | 26 (70%) | 10 (14%) | <0.01 |